LENSAR to Present at the 32nd Annual Piper Sandler Virtual Healthcare Conference
November 23 2020 - 8:00AM
Business Wire
LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a
global medical technology company focused on femtosecond laser
surgical solutions for the treatment of cataracts, today announced
that Nick Curtis, Chief Executive Officer will present at the 32nd
Annual Piper Sandler Virtual Healthcare Conference. Mr. Curtis’
presentation will be available on-demand beginning at 10:00 a.m.
Eastern Time, and can be accessed through the Investors section of
the Company's website at https://ir.lensar.com on November 23, 2020
at 10 a.m. Eastern Time. The webcast will be available for two
weeks after the presentation has been posted.
Additionally, Mr. Curtis will be participating in one-on-one
meetings with conference attendees on December 1 and 2, 2020.
Investors interested in meeting with LENSAR management may request
a meeting through Piper Sandler, or by contacting Lee Roth at
lroth@burnsmc.com.
About LENSAR
LENSAR is a commercial-stage medical device company focused on
designing, developing and marketing an advanced femtosecond laser
system for the treatment of cataracts and the management of
pre-existing or surgically induced corneal astigmatism. Its LENSAR
Laser System incorporates a range of proprietary technologies
designed to assist the surgeon in obtaining better visual outcomes,
efficiency and reproducibility by providing advanced imaging,
simplified procedure planning, efficient design and precision.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201123005637/en/
Thomas R. Staab, II, CFO ir.contact@lensar.com
Lee Roth / Cameron Radinovic Burns McClellan for LENSAR
lroth@burnsmc.com / cradinovic@burnsmc.com
LENSAR (NASDAQ:LNSR)
Historical Stock Chart
From Apr 2024 to May 2024
LENSAR (NASDAQ:LNSR)
Historical Stock Chart
From May 2023 to May 2024